S
PTCT icon

SignatureFD’s PTC Therapeutics PTCT Stock Holding History

SignatureFD’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1K Sell
393
-7
-2% -$505 ﹤0.01% 2118
2026
Q1 		$27.3K Buy
400
+37
+10% +$2.62K ﹤0.01% 2060
2025
Q4 		$27.6K Hold
363
– – ﹤0.01% 1966
2025
Q3 		$22.3K Hold
363
– – ﹤0.01% 2062
2025
Q2 		$17.7K Sell
363
-17
-4% -$807 ﹤0.01% 2098
2025
Q1 		$19.4K Buy
380
+17
+5% +$848 ﹤0.01% 2075
2024
Q4 		$16.4K Hold
363
– – ﹤0.01% 2159
2024
Q3 		$13.5K Sell
363
-22
-6% -$737 ﹤0.01% 2222
2024
Q2 		$11.8K Buy
385
+66
+21% +$2.14K ﹤0.01% 2201
2024
Q1 		$9.28K Sell
319
-134
-30% -$3.75K ﹤0.01% 2325
2023
Q4 		$12.5K Buy
453
+384
+557% +$8.78K ﹤0.01% 2155
2023
Q3 		$1.55K Buy
69
+24
+53% +$893 ﹤0.01% 2839
2023
Q2 		$1.83K Sell
45
-25
-36% -$1.22K ﹤0.01% 2833
2023
Q1 		$3.39K Buy
70
+25
+56% +$1.14K ﹤0.01% 2649
2022
Q4 		$1.72K Sell
45
-42
-48% -$1.75K ﹤0.01% 2855
2022
Q3 		$4K Buy
87
+42
+93% +$2.06K ﹤0.01% 2558
2022
Q2 		$2K Sell
45
-95
-68% -$3.33K ﹤0.01% 2791
2022
Q1 		$5K Buy
140
+58
+71% +$2.23K ﹤0.01% 2502
2021
Q4 		$3K Buy
82
+59
+257% +$2.26K ﹤0.01% 2610
2021
Q3 		$1K Buy
+23
New +$945 ﹤0.01% 2893
2021
Q2 		– Sell
-207
Closed -$10K – 3035
2021
Q1 		$10K Buy
207
+13
+7% +$772 ﹤0.01% 1861
2020
Q4 		$12K Buy
194
+9
+5% +$530 ﹤0.01% 1641
2020
Q3 		$9K Buy
+185
New +$9.11K ﹤0.01% 1682

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

SignatureFD's PTCT Position: Q2 2026 in Review

SignatureFD reduced its PTC Therapeutics (PTCT) stake by 1.8% in Q2 2026, selling an estimated $505 and leaving 393 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

SignatureFD first reported a position in PTCT in Q3 2020 and has held it in 23 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • SignatureFD held 393 shares of PTC Therapeutics worth $32.1K as of Q2 2026.
  • SignatureFD sold 7 PTC Therapeutics shares in Q2 2026, an estimated $505.
  • PTC Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2118 holding.
  • SignatureFD first reported a position in PTC Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.